Lord, Abbett & Co’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-147,386
| Closed | -$5.28M | – | 663 |
|
|
2020
Q3 | $5.28M | Sell |
147,386
-9,008
| -6% | -$323K | 0.02% | 561 |
|
|
2020
Q2 | $3.78M | Sell |
156,394
-83,108
| -35% | -$2.01M | 0.01% | 592 |
|
|
2020
Q1 | $4.19M | Buy |
239,502
+6,860
| +3% | +$120K | 0.02% | 556 |
|
|
2019
Q4 | $4.05M | Sell |
232,642
-937,242
| -80% | -$16.3M | 0.01% | 611 |
|
|
2019
Q3 | $17.9M | Sell |
1,169,884
-576,042
| -33% | -$8.83M | 0.06% | 427 |
|
|
2019
Q2 | $36.2M | Buy |
1,745,926
+89,677
| +5% | +$1.86M | 0.12% | 298 |
|
|
2019
Q1 | $38.5M | Buy |
1,656,249
+217,641
| +15% | +$5.05M | 0.13% | 258 |
|
|
2018
Q4 | $29.7M | Buy |
1,438,608
+313,153
| +28% | +$6.47M | 0.11% | 290 |
|
|
2018
Q3 | $24.5M | Buy |
1,125,455
+761,599
| +209% | +$16.6M | 0.07% | 430 |
|
|
2018
Q2 | $5.55M | Buy |
363,856
+79,244
| +28% | +$1.21M | 0.02% | 725 |
|
|
2018
Q1 | $5.6M | Buy |
+284,612
| New | +$5.6M | 0.02% | 707 |
|